News2 mins ago
Myeloid Therapeutics to Participate at SVB Securities Biopharma Company Connect Event
CAMBRIDGE, Mass., May 23, 2023 /PRNewswire/ — Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage mRNA-immunotherapy company, today announced that it will participate in the SVB Securities...
